ADHD Medication and Predictors of Treatment Outcome

CompletedOBSERVATIONAL

Enrollment

632

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2021

Study Completion Date

June 30, 2022

Conditions

Attention Deficit Disorder With Hyperactivity (ADHD)

Interventions

DRUG

methylphenidate medication

DRUG

atomoxetine medication

DRUG

lisdexamphetamine medication

DRUG

guanfacine medication

Trial Locations (1)

Division for Child and Adolescent Psychiatry in Stockholm, Stockholm

All Listed Sponsors

lead

Karolinska Institutet

OTHER

NCT02136147 - ADHD Medication and Predictors of Treatment Outcome | Biotech Hunter | Biotech Hunter